Role of microRNA29b in blood-brain barrier dysfunction during hyperhomocysteinemia: An epigenetic mechanism

Journal of Cerebral Blood Flow and Metabolism

Volumn 34, Issue 7, 2014, Pages 1212-1222

  Kalani, Anuradha ^a   Kamat, Pradip K ^a   Familtseva, Anastasia ^a   Chaturvedi, Pankaj ^a   Muradashvili, Nino ^a   Narayanan, Nithya ^a   Tyagi, Suresh C ^a   Tyagi, Neetu ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

5' azacytidine; bloodbrain barrier; endothelial cells; homocysteine; microRNA

Indexed keywords

AZACITIDINE; CYSTATHIONINE BETA SYNTHASE; DNA METHYLTRANSFERASE 3B; GELATINASE B; HOMOCYSTEINE; METALLOPROTEINASE; MICRORNA 29B; REACTIVE OXYGEN METABOLITE; VASCULAR ENDOTHELIAL CADHERIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; BRAIN BLOOD VESSEL; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; EPIGENETICS; HYPERHOMOCYSTEINEMIA; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCYTOSIS;

ANIMALS; BLOOD-BRAIN BARRIER; BLOTTING, WESTERN; CAPILLARY PERMEABILITY; DISEASE MODELS, ANIMAL; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; EPIGENESIS, GENETIC; FLOW CYTOMETRY; HYPERHOMOCYSTEINEMIA; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRORNAS; MICROSCOPY, CONFOCAL; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84903789514     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2014.74     Document Type: Article

References (43)

1. Abbott NJ, Ronnback L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006; 7: 41-53
2. Ballabh P, Braun A, Nedergaard M. The blood-brain barrier: An overview: Structure, regulation, and clinical implications. Neurobiol Dis 2004; 16: 1-13
3. Rhodehouse BC, Mayo JN, Beard Jr. RS, Chen CH, Bearden SE. Opening of the blood-brain barrier before cerebral pathology in mild hyperhomocysteinemia. PLoS One 2013; 8: E63951
4. Liu WY, Wang ZB, Zhang LC, Wei X, Li L. Tight junction in blood-brain barrier: An overview of structure, regulation, and regulator substances. CNS Neurosci Ther 2012; 18: 609-615
5. Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, Callegari E et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci USA 2007; 104: 15805-15810
6. Garzon R, Liu S, Fabbri M, Liu Z, Heaphy CE, Callegari E et al. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood 2009; 113: 6411-6418
7. Khanna S, Rink C, Ghoorkhanian R, Gnyawali S, Heigel M, Wijesinghe DS et al. Loss of miR-29b following acute ischemic stroke contributes to neural cell death and infarct size. J Cereb Blood Flow Metab 2013; 33: 1197-1206
8. Shi G, Liu Y, Liu T, Yan W, Liu X, Wang Y et al. Upregulated miR-29b promotes neuronal cell death by inhibiting Bcl2L2 after ischemic brain injury. Exp Brain Res 2012; 216: 225-230
9. Beard Jr. RS, Bearden SE. Vascular complications of cystathionine beta-synthase deficiency: Future directions for homocysteine-To-hydrogen sulfide research. Am J Physiol Heart Circ Physiol 2011; 300: H13-H26
10. Lominadze D, Roberts AM, Tyagi N, Moshal KS, Tyagi SC. Homocysteine causes cerebrovascular leakage in mice. Am J Physiol Heart Circ Physiol 2006; 290: H1206-H1213
11. Kamath AF, Chauhan AK, Kisucka J, Dole VS, Loscalzo J, Handy DE et al. Elevated levels of homocysteine compromise blood-brain barrier integrity in mice. Blood 2006; 107: 591-593
12. Qipshidze N, Metreveli N, Lominadze D, Tyagi SC. Folic acid improves acetylcholine-induced vasoconstriction of coronary vessels isolated from hyperhomocysteinemic mice: An implication to coronary vasospasm. J Cell Physiol 2011; 226: 2712-2720
13. Tyagi SC, Lominadze D, Roberts AM. Homocysteine in microvascular endothelial cell barrier permeability. Cell Biochem Biophys 2005; 43: 37-44
14. Kalani A, Kamat PK, Tyagi SC, Tyagi N. Synergy of homocysteine, microRNA, and epigenetics: A novel therapeutic approach for stroke. Mol Neurobiol 2013; 48: 157-168
15. Kang SK, Lee DH, Bae YC, Kim HK, Baik SY, Jung JS. Improvement of neurological deficits by intracerebral transplantation of human adipose tissue-derived stromal cells after cerebral ischemia in rats. Exp Neurol 2003; 183: 355-366
16. Lee TH, Yoon JG. Intracerebral transplantation of human adipose tissue stromal cells after middle cerebral artery occlusion in rats. J Clin Neurosci 2008; 15: 907-912
17. Blum W, Garzon R, Klisovic RB, Schwind S, Walker A, Geyer S et al. Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine. Proc Natl Acad Sci USA 2010; 107: 7473-7478
18. Yang H, Fang Z, Wei Y, Hu Y, Calin GA, Kantarjian HM et al. Levels of miR-29b do not predict for response in patients with acute myelogenous leukemia treated with the combination of 5-Azacytidine, valproic acid, and ATRA. Am J Hematol 2011; 86: 237-238
19. Brown RC, Morris AP, O'Neil RG. Tight junction protein expression and barrier properties of immortalized mouse brain microvessel endothelial cells. Brain Res 2007; 1130: 17-30
20. Watanabe T, Dohgu S, Takata F, Nishioku T, Nakashima A, Futagami K et al. Paracellular barrier and tight junction protein expression in the immortalized brain endothelial cell lines bEND.3, bEND.5 and mouse brain endothelial cell 4. Biol Pharm Bull 2013; 36: 492-495
21. Muradashvili N, Tyagi R, Lominadze D. A dual-Tracer method for differentiating transendothelial transport from paracellular leakage in vivo and in vitro. Front Physiol 2012; 3: 166
22. Munjal C, Tyagi N, Lominadze D, Tyagi SC. Matrix metalloproteinase-9 in homocysteine-induced intestinal microvascular endothelial paracellular and transcellular permeability. J Cell Biochem 2012; 113: 1159-1169
23. Kalani A, Kamat PK, Givvimani S, Brown K, Metreveli N, Tyagi SC et al. Nutriepigenetics ameliorates blood-brain barrier damage and neurodegeneration in hyperhomocysteinemia: Role of folic acid. J Mol Neurosci 2013; 52: 202-215
24. Tyagi N, Moshal KS, Sen U, Vacek TP, Kumar M, Hughes Jr. WM et al. H2S protects against methionine-induced oxidative stress in brain endothelial cells. Antioxid Redox Signal 2009; 11: 25-33
25. Tyagi N, Qipshidze N, Sen U, Rodriguez W, Ovechkin A, Tyagi SC. Cystathionine beta synthase gene dose dependent vascular remodeling in murine model of hyperhomocysteinemia. Int J Physiol Pathophysiol Pharmacol 2011; 3: 210-222
26. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005; 438: 685-689
27. Elmen J, Lindow M, Schutz S, Lawrence M, Petri A, Obad S et al. LNA-mediated microRNA silencing in non-human primates. Nature 2008; 452: 896-899
28. Kamat PK, Kalani A, Givvimani S, Sathnur PB, Tyagi SC, Tyagi N. Hydrogen sulfide attenuates neurodegeneration and neurovascular dysfunction induced by intracerebral-Administered homocysteine in mice. Neuroscience 2013; 252: 302-319
29. Moustapha A, Gupta A, Robinson K, Arheart K, Jacobsen DW, Schreiber MJ et al. Prevalence and determinants of hyperhomocysteinemia in hemodialysis and peritoneal dialysis. Kidney Int 1999; 55: 1470-1475
30. Ueland PM, Refsum H. Plasma homocysteine, a risk factor for vascular disease: Plasma levels in health, disease, and drug therapy. J Lab Clin Med 1989; 114: 473-501
31. Hassan A, Hunt BJ, O'Sullivan M, Bell R, D'Souza R, Jeffery S et al. Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain 2004; 127: 212-219
32. Kumar M, Tyagi N, Moshal KS, Sen U, Pushpakumar SB, Vacek T et al. GABAA receptor agonist mitigates homocysteine-induced cerebrovascular remodeling in knockout mice. Brain Res 2008; 1221: 147-153
33. Beard Jr. RS, Reynolds JJ, Bearden SE. Hyperhomocysteinemia increases permeability of the blood-brain barrier by NMDA receptor-dependent regulation of adherens and tight junctions. Blood 2011; 118: 2007-2014
34. Takada S, Berezikov E, Choi YL, Yamashita Y, Mano H. Potential role of miR-29b in modulation of Dnmt3a and Dnmt3b expression in primordial germ cells of female mouse embryos. RNA 2009; 15: 1507-1514
35. Rosell A, Alvarez-Sabin J, Arenillas JF, Rovira A, Delgado P, Fernández-Cadenas I et al. A matrix metalloproteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke. Stroke 2005; 36: 1415-1420
36. Tyagi N, Gillespie W, Vacek JC, Sen U, Tyagi SC, Lominadze D. Activation of GABAA receptor ameliorates homocysteine-induced MMP-9 activation by ERK pathway. J Cell Physiol 2009; 220: 257-266
37. Moshal KS, Tipparaju SM, Vacek TP, Kumar M, Singh M, Frank IE et al. Mitochondrial matrix metalloproteinase activation decreases myocyte contractility in hyperhomocysteinemia. Am J Physiol Heart Circ Physiol 2008; 295: H890-H897
38. Sudduth TL, Powell DK, Smith CD, Greenstein A, Wilcock DM. Induction of hyperhomocysteinemia models vascular dementia by induction of cerebral microhemorrhages and neuroinflammation. J Cereb Blood Flow Metab 2013; 33: 708-715
39. Chen KC, Wang YS, Hu CY, Chang WC, Liao YC, Dai CY et al. OxLDL up-regulates microRNA-29b, leading to epigenetic modifications of MMP-2/MMP-9 genes: A novel mechanism for cardiovascular diseases. FASEB J 2011; 25: 1718-1728
40. Krutzfeldt J, Kuwajima S, Braich R, Rajeev KG, Pena J, Tuschl T et al. Specificity, duplex degradation and subcellular localization of antagomirs. Nucleic Acids Res 2007; 35: 2885-2892
41. Zhou Q, Souba WW, Croce CM, Verne GN. MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome. Gut 2010; 59: 775-784
42. Wang Y, Liu C, Guo QL, Yan JQ, Zhu XY, Huang CS et al. Intrathecal 5-Azacytidine inhibits global DNA methylation and methyl-CpG-binding protein 2 expression and alleviates neuropathic pain in rats following chronic constriction injury. Brain Res 2011; 1418: 64-69
43. Zhang R, Kang KA, Kim KC, Na SY, Chang WY, Kim GY et al. Oxidative stress causes epigenetic alteration of CDX1 expression in colorectal cancer cells. Gene 2013; 524: 214-219